Structural and mechanistic insights into ras association domains of phospholipase C epsilon.

Ras proteins signal to a number of distinct pathways by interacting with diverse effectors. Studies of ras/effector interactions have focused on three classes, Raf kinases, ral guanylnucleotide-exchange factors, and phosphatidylinositol-3-kinases. Here we describe ras interactions with another effector, the recently identified phospholipase C epsilon (PLCepsilon). We solved structures of PLCepsilon RA domains (RA1 and RA2) by NMR and the structure of the RA2/ras complex by X-ray crystallography. Although the similarity between ubiquitin-like folds of RA1 and RA2 proves that they are homologs, only RA2 can bind ras. Some of the features of the RA2/ras interface are unique to PLCepsilon, while the ability to make contacts with both switch I and II regions of ras is shared only with phosphatidylinositol-3-kinase. Studies of PLCepsilon regulation suggest that, in a cellular context, the RA2 domain, in a mode specific to PLCepsilon, has a role in membrane targeting with further regulatory impact on PLC activity.

[1]  P. Gierschik,et al.  Stimulation of phospholipase C-β2 by Rho GTPases , 2000 .

[2]  F. McCormick,et al.  Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate , 2004, Molecular and Cellular Biology.

[3]  P. Hawkins,et al.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.

[4]  P. Sugden,et al.  Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants , 2005, Oncogene.

[5]  C. Kiel,et al.  The Activation of RalGDS Can Be Achieved Independently of Its Ras Binding Domain , 2002, The Journal of Biological Chemistry.

[6]  M. Machius,et al.  Structural basis of Rho GTPase-mediated activation of the formin mDia1. , 2005, Molecular cell.

[7]  T. K. Harden,et al.  RhoA Activates Purified Phospholipase C-ϵ by a Guanine Nucleotide-dependent Mechanism* , 2004, Journal of Biological Chemistry.

[8]  C. Herrmann.  Ras-effector interactions: after one decade. , 2003, Current opinion in structural biology.

[9]  Chris P. Ponting,et al.  A novel family ofras-binding domains , 1996 .

[10]  T. Kataoka,et al.  Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. , 2001, The Journal of biological chemistry.

[11]  Christina Kiel,et al.  Recognizing and defining true Ras binding domains I: biochemical analysis. , 2005, Journal of molecular biology.

[12]  K. Jakobs,et al.  A new phospholipase-C–calcium signalling pathway mediated by cyclic AMP and a Rap GTPase , 2001, Nature Cell Biology.

[13]  A. Smrcka,et al.  Phospholipase Cϵ: a novel Ras effector , 2001 .

[14]  Michiyuki Matsuda,et al.  Ras binding opens c‐Raf to expose the docking site for mitogen‐activated protein kinase kinase , 2005, EMBO reports.

[15]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[16]  T. Kataoka,et al.  Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase Cε , 2002, Oncogene.

[17]  Phillip T. Hawkins,et al.  Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ , 2000, Cell.

[18]  P. Hawkins,et al.  Activation of Phosphoinositide 3-Kinase γ by Ras , 2002, Current Biology.

[19]  P. M. Campbell,et al.  Oncogenic Ras and its role in tumor cell invasion and metastasis. , 2004, Seminars in cancer biology.

[20]  C. Der,et al.  Signaling Interplay in Ras Superfamily Function , 2005, Current Biology.

[21]  C. Marshall,et al.  RalA interacts with ZONAB in a cell density‐dependent manner and regulates its transcriptional activity , 2005, The EMBO journal.

[22]  P. Driscoll,et al.  Characterization and manipulation of the Pseudomonas aeruginosa dimethylarginine dimethylaminohydrolase monomer--dimer equilibrium. , 2004, Journal of molecular biology.

[23]  P. Gierschik,et al.  Stimulation of phospholipase C-beta 2 by Rho GTPases. , 2000, Methods in enzymology.

[24]  A. Smrcka,et al.  Phospholipase C(epsilon): a novel Ras effector. , 2001, The EMBO journal.

[25]  S. Rhee,et al.  Regulation of phosphoinositide-specific phospholipase C. , 2001, Annual review of biochemistry.

[26]  Ralf Janknecht,et al.  Ras/Rap effector specificity determined by charge reversal , 1996, Nature Structural Biology.

[27]  T Kendall Harden,et al.  PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. , 2003, Molecular interventions.

[28]  S. Maeda,et al.  Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. , 2004, Cancer research.

[29]  A. Smrcka,et al.  Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. , 2004, The Biochemical journal.

[30]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[31]  R. Thapar,et al.  NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation. , 2004, Journal of molecular biology.

[32]  P. Hawkins,et al.  Activation of phosphoinositide 3-kinase gamma by Ras. , 2002, Current biology : CB.

[33]  Gudrun Horn,et al.  Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor , 1996, The Journal of Biological Chemistry.

[34]  C P Ponting,et al.  A novel family of Ras-binding domains. , 1996, Trends in biochemical sciences.

[35]  T. Kataoka,et al.  Regulation of a Novel Human Phospholipase C, PLCε, through Membrane Targeting by Ras* , 2001, The Journal of Biological Chemistry.

[36]  Yunfeng Bai,et al.  Crucial Role of Phospholipase Cε in Chemical Carcinogen-Induced Skin Tumor Development , 2004, Cancer Research.